California Rare Disease Access Coalition

07/29/2026

Social determinants of health account for up to 80% of health outcomes in the U.S. Integrating interventions into health care can improve outcomes, reduce avoidable care, and advance more equitable, whole-person care.
Read more here: https://tinyurl.com/3xwjdf7z

07/28/2026

A recent study found that children with hemophilia A have distinct immune and inflammatory reactions, suggesting that the type of preventive treatment they receive may influence their responses.
Read more here:

Hemophilia A treatments were linked to different immune patterns in children in a small study of Hemlibra and factor VIII therapy.

07/24/2026

Copay accumulators let insurers & keep your copay assistance without counting toward your deductible. When it runs out, you pay again. Proud to join 90+ orgs urging & to enforce EHB protections & ensure . https://bit.ly/4bNEJ7k

07/23/2026

Gene therapy is transforming medicine by targeting disease at its source, offering new hope for patients with Huntington’s disease, sickle cell disease, inherited neurological disorders, and other genetic conditions.
Read more here:

Find out how gene therapy is changing how we treat disease with groundbreaking research and innovative technologies leading the way.

07/22/2026

We are proud to join 90+ patient and provider groups in urging to strengthen prescription drug coverage and enforce Essential Health Benefits (EHB) protections. Read the letter here: https://bit.ly/4bNEJ7k

07/22/2026

Join NORD for two free, virtual Living Rare, Living Stronger® webinars designed for patients, caregivers and families navigating a rare disease.

From 3-4 p.m. ET on July 30, learn about common insurance barriers and practical tips to overcome them. RSVP: https://bit.ly/4pqrkIc

From 3-4 p.m. ET on Aug. 27, explore new approaches to improving your rare disease care. RSVP: https://bit.ly/4vZmIei

Both sessions include live Q&A and allow you to submit questions in advance. They will both be recorded for those who cannot tune in live!

07/21/2026

A new rare disease initiative aims to strengthen communities and clinical studies, helping patients, physicians, and scientists work together to advance research and identify new treatment opportunities.
Read more here:

Chan Zuckerberg Initiative's Biohub will offer new grants to the rare disease community while expanding its AI drug repurposing partnership with Every Cure.

07/16/2026

A new gene therapy for rare immune disorder shows promise in early pre-clinical studies for the treatment of CTLA-4 insufficiency.
Read more here:

The development of a pioneering gene therapy to treat a devastating, rare immune disorder led by UCL scientists is set to move into its next phase following promising early pre-clinical studies.

07/11/2026

Another advocacy opportunity for the rare disease community!